Pulmonary vein isolation is an emerging therapy for atrial fibrillation in patients with congenital heart disease, though complex anatomies and coexisting macroreentrant tachycardias contribute to variable recurrence rates.
Atrial fibrillation (AF) is the next major challenge in management of patients with congenital heart disease (CHD). This tachyarrhythmia arises at a relatively young age and rapidly progresses from paroxysmal to long-standing persistent AF in <5 years, which justifies aggressive therapy.
No takes yet. Share an insight, caveat, or question.
Groot et al. (2024) conducted an editorial in Atrial fibrillation in congenital heart disease. Catheter ablation (Pulmonary vein isolation) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: